ClinShield

Clinical Trial Protocol Compliance Analysis

Report Generated: January 12, 2026

Protocol Information

Protocol File
Sample Protocol (Anonymized)
Pages Analyzed
3
Sections Detected
0
Analysis Date
2026-01-12
Compliance Score
5
Grade
F

Executive Summary

12
Total Findings
7
Critical
5
Major
0
Minor

Severity Breakdown: HIGH: 7, MEDIUM: 5

Overall Assessment

Unacceptable compliance. The protocol has critical gaps that require major revision before regulatory submission.

Findings

CRITICAL Findings (7)

Finding #1: ICH_E6_R2_6.5
HIGH CRITICAL 100% Confidence
Requirement

The protocol should specify inclusion and exclusion criteria for subject selection.

Evidence

Sections Searched: 1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 3.1

Synonyms Tried: Inclusion Criteria, Exclusion Criteria, Subject Selection, Eligibility, Eligibility Criteria, Selection Criteria

Pages Checked: 1, 2, 3

Finding #2: ICH_E6_R2_6.7
HIGH CRITICAL 100% Confidence
Requirement

The protocol should specify efficacy parameters and assessment methods.

Evidence

Sections Searched: 1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 3.1

Synonyms Tried: Efficacy, Endpoints, Primary Endpoint, Efficacy Assessment, Outcome Measures, Assessments

Pages Checked: 1, 2, 3

Finding #3: ICH_E6_R2_6.8
HIGH CRITICAL 100% Confidence
Requirement

The protocol should specify safety parameters, adverse event reporting, and safety monitoring procedures.

Evidence

Sections Searched: 1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 3.1

Synonyms Tried: Safety, Adverse Events, Safety Assessment, AE Reporting, Safety Monitoring, Toxicity

Pages Checked: 1, 2, 3

Finding #4: ICH_E6_R2_6.9
HIGH CRITICAL 100% Confidence
Requirement

The protocol should include statistical methods, sample size calculation, and analysis plan.

Evidence

Sections Searched: 1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 3.1

Synonyms Tried: Statistics, Statistical Analysis, Sample Size, Statistical Methods, Analysis Plan, Statistical Plan

Pages Checked: 1, 2, 3

Finding #5: ICH_E6_R2_5.18
HIGH CRITICAL 100% Confidence
Requirement

The sponsor should ensure adequate trial monitoring. For certain trials, a Data Safety Monitoring Board (DSMB) should be established.

Evidence

Sections Searched: 1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 3.1

Synonyms Tried: DSMB, DMC, Data Monitoring Committee, Safety Monitoring Committee, Data Safety Monitoring, Independent Safety Committee

Pages Checked: 1, 2, 3

Finding #6: ICH_E6_R2_4.8
HIGH CRITICAL 100% Confidence
Requirement

The protocol should describe the informed consent process and include consent form templates.

Evidence

Sections Searched: 1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 3.1

Synonyms Tried: Informed Consent, Consent Process, Consent, ICF, Consent Form, Subject Consent

Pages Checked: 1, 2, 3

Finding #7: ICH_E6_R2_3.1
HIGH CRITICAL 100% Confidence
Requirement

The protocol should describe the ethics committee review process and IRB approval requirements.

Evidence

Sections Searched: 1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 3.1

Synonyms Tried: Ethics Committee, IRB, Institutional Review Board, Ethics Review, Ethics Approval, IRB Approval

Pages Checked: 1, 2, 3

MAJOR Findings (5)

Finding #8: ICH_E6_R2_6.1
MEDIUM MAJOR 100% Confidence
Requirement

The protocol should include a title page with protocol title, version number, and date.

Evidence

Sections Searched: 1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 3.1

Synonyms Tried: Title Page, Protocol Title, Version Control, Protocol Version

Pages Checked: 1, 2, 3

Finding #9: ICH_E6_R2_6.6
MEDIUM MAJOR 100% Confidence
Requirement

The protocol should describe the treatment regimen, dosing schedule, and administration procedures.

Evidence

Sections Searched: 1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 3.1

Synonyms Tried: Treatment, Dosing, Drug Administration, Treatment Regimen, Dosing Schedule, Study Treatment

Pages Checked: 1, 2, 3

Finding #10: ICH_E6_R2_5.1
MEDIUM MAJOR 100% Confidence
Requirement

The sponsor should implement quality control and quality assurance systems.

Evidence

Sections Searched: 1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 3.1

Synonyms Tried: Quality Control, Quality Assurance, QC, QA, Quality Management, Quality Systems

Pages Checked: 1, 2, 3

Finding #11: ICH_E6_R2_5.5
MEDIUM MAJOR 100% Confidence
Requirement

The sponsor should use data management procedures to ensure data quality and integrity.

Evidence

Sections Searched: 1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 3.1

Synonyms Tried: Data Management, Data Handling, Data Collection, EDC, Case Report Forms, CRF

Pages Checked: 1, 2, 3

Finding #12: ICH_E6_R2_8.1
MEDIUM MAJOR 100% Confidence
Requirement

The protocol should reference essential documents required for trial conduct and regulatory submission.

Evidence

Sections Searched: 1.0, 1.1, 2.0, 2.1, 2.2, 3.0, 3.1

Synonyms Tried: Essential Documents, Regulatory Documents, Trial Documents, Study Documents

Pages Checked: 1, 2, 3

Scoring Breakdown

Base Score: 100

Severity Count Points Each Total Deduction
HIGH 7 10 -70
MEDIUM 5 5 -25
LOW 0 2 -0
Final Score 5

Formula Version: 1.0.0

Recommendations

FDA AI Guidance Compliance

This analysis follows the FDA's January 2025 guidance "Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products."

Context of Use

Pre-submission protocol compliance review to identify regulatory gaps before filing.

Risk Assessment

Deterministic Checking (Primary Layer)
  • Technology: Rule-based pattern matching
  • Risk Level: LOW (fully explainable, no ML)
  • Purpose: Structural compliance verification
AI Quality Analysis (Optional Enhancement)
  • Technology: Large Language Model
  • Risk Level: MEDIUM (advisory only)
  • Purpose: Content quality assessment

Credibility Evidence

  • 15+ ICH E6 (R2) requirements evaluated
  • Complete search evidence provided for each finding
  • Transparent, auditable methodology

Decision Authority

Final compliance determination remains with protocol sponsor and regulatory authorities. ClinShield is an advisory tool designed to support, not replace, expert judgment.